{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:51:59Z","timestamp":1781646719776,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010104","name":"Zhengzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["Y20220126"],"award-info":[{"award-number":["Y20220126"]}],"id":[{"id":"10.13039\/100010104","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province","award":["2022E10022"],"award-info":[{"award-number":["2022E10022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Inherited antithrombin deficiency (ATD), a rare autosomal dominant disorder due to\n                      <jats:italic>SERPINC1<\/jats:italic>\n                      gene mutations, is the most severe inherited thrombophilia. Limited literature exists that focuses on ATD and its mutations in the Chinese population. This study aimed to characterize\n                      <jats:italic>SERPINC1<\/jats:italic>\n                      gene mutations in a Chinese cohort and to explore their relationship with thrombophilia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Coagulation screening results and clinical data were meticulously collected from 23 unrelated probands with ATD and their family members. Genomic DNA was extracted and subjected to PCR amplification and direct sequencing. Putative mutations were analyzed using in silico bioinformatic tools. Mutant antithrombin (AT) proteins were expressed in HEK293 cells, and ELISA was used to detect wild-type and mutant AT. RT-qPCR was used to measure AT mRNA expression in transfected cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 23 probands, 15 (65.2%) exhibited concurrent reductions in both AT: A and AT: Ag (type I defects), while the remaining 8 (34.8%) had normal AT: Ag levels (type II defects). Genetic analysis revealed a spectrum of 21 distinct mutations across 87.0% (20\/23) of the probands. Most were point mutations predicted to be deleterious and were primarily located in exons 5 and 3. Among the 20 mutation carriers, 15 (75%) were heterozygous and most of them experienced thrombosis with identifiable triggers. The other 5 (25%) were compound heterozygous and primarily presented with spontaneous thrombosis. Notably, the missense mutations c.1346T\u2009&gt;\u2009A and c.442T\u2009&gt;\u2009C were recurrent. These mutations exhibited high heterogeneity, with no ethnic-specific mutations observed. In vitro expression confirmed that synthesis and\/or secretion defects in the mutant proteins are the primary mechanism underlying the antithrombin deficiency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:italic>SERPINC1<\/jats:italic>\n                      gene analysis benefits asymptomatic family members, especially child-bearing women, by informing venous thromboembolism prevention strategies and guiding anticoagulant choice in cases involving heparin-binding site mutations. This underscores the essential role of genetic diagnosis in ATD management.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04200-0","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:00:11Z","timestamp":1774522811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SERPINC1 mutations and thrombotic events in inherited antithrombin deficiency: a study on the han population of East China"],"prefix":"10.1186","volume":"21","author":[{"given":"Fei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqing","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixiao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"issue":"4","key":"4200_CR1","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/jth.13960","volume":"16","author":"J Sokol","year":"2018","unstructured":"Sokol J, Timp JF, le Cessie S, et al. Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow-up study. J Thromb Haemostasis: JTH. 2018;16(4):680\u20138. https:\/\/doi.org\/10.1111\/jth.13960.","journal-title":"J Thromb Haemostasis: JTH"},{"key":"4200_CR2","unstructured":"Online Mendelian Inheritance in Man, OMIM. John Hopkins University, Baltimore, MD. http:\/\/www.ncbi.nlm.nih.gov\/omim\/ Accessed 10 Mar 2024."},{"issue":"1","key":"4200_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12959-024-00677-6","volume":"22","author":"SW Lai","year":"2024","unstructured":"Lai SW, Chang CY, et al. Identification of two point mutations associated with inherited antithrombin deficiency. Thromb J. 2024;22(1):107. https:\/\/doi.org\/10.1186\/s12959-024-00677-6.","journal-title":"Thromb J"},{"issue":"6","key":"4200_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/17474086.2019.1611424","volume":"12","author":"C Bravo-P\u00e9rez","year":"2019","unstructured":"Bravo-P\u00e9rez C, Vicente V, Corral J. Management of antithrombin deficiency: an update for clinicians. Expert Rev Hematol. 2019;12(6):397\u2013405. https:\/\/doi.org\/10.1080\/17474086.2019.1611424.","journal-title":"Expert Rev Hematol"},{"issue":"1","key":"4200_CR5","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s13023-024-03498-y","volume":"19","author":"H Zhang","year":"2024","unstructured":"Zhang H, Yue X, Dai T, et al. Clinical and functional characterization of p.Lys322stop variant in the SERPINC1 gene causing severe thrombophilia. Orphanet J Rare Dis. 2024;19(1):480. https:\/\/doi.org\/10.1186\/s13023-024-03498-y.","journal-title":"Orphanet J Rare Dis"},{"key":"4200_CR6","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jss.2020.07.010","volume":"256","author":"JD Ehrhardt Jr","year":"2020","unstructured":"Ehrhardt JD Jr, Boneva D, McKenney M, et al. Antithrombin deficiency in trauma and surgical critical care. J Surg Res. 2020;256:536\u201342. https:\/\/doi.org\/10.1016\/j.jss.2020.07.010.","journal-title":"J Surg Res"},{"issue":"4","key":"4200_CR7","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s11239-020-02090-y","volume":"49","author":"G Colucci","year":"2020","unstructured":"Colucci G, Tsakiris DA. Thrombophilia screening revisited: an issue of personalized medicine. J Thromb Thrombolysis. 2020;49(4):618\u201329. https:\/\/doi.org\/10.1007\/s11239-020-02090-y.","journal-title":"J Thromb Thrombolysis"},{"issue":"19","key":"4200_CR8","doi-asserted-by":"publisher","first-page":"e161430","DOI":"10.1172\/jci.insight.161430","volume":"7","author":"C Bravo-P\u00e9rez","year":"2022","unstructured":"Bravo-P\u00e9rez C, Toderici M, Chambers JE, et al. Full-length antithrombin frameshift variant with aberrant C-terminus causes Endoplasmic reticulum retention with a dominant-negative effect. JCI Insight. 2022;7(19):e161430. https:\/\/doi.org\/10.1172\/jci.insight.161430.","journal-title":"JCI Insight"},{"issue":"6","key":"4200_CR9","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3390\/genes12060934","volume":"12","author":"D Gemmati","year":"2021","unstructured":"Gemmati D, Longo G, Franchini E, et al. Cis-Segregation of c.1171C\u2009>\u2009T stop codon (p.R391*) in SERPINC1 gene and c.1691G\u2009>\u2009A transition (p.R506Q) in F5 gene and selected GWAS multilocus approach in inherited thrombophilia. Genes. 2021;12(6):934. https:\/\/doi.org\/10.3390\/genes12060934.","journal-title":"Genes"},{"issue":"1","key":"4200_CR10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1182\/blood-2014-03-561027","volume":"124","author":"Y Liu","year":"2014","unstructured":"Liu Y, Kretz CA, Maeder ML, et al. Targeted mutagenesis of zebrafish antithrombin III triggers disseminated intravascular coagulation and thrombosis, revealing insight into function. Blood. 2014;124(1):142\u201350. https:\/\/doi.org\/10.1182\/blood-2014-03-561027.","journal-title":"Blood"},{"issue":"2","key":"4200_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1182\/blood.2021014708","volume":"140","author":"ME de la Morena-Barrio","year":"2022","unstructured":"de la Morena-Barrio ME, Suchon P, Jacobsen EM, et al. Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays. Blood. 2022;140(2):140\u201351. https:\/\/doi.org\/10.1182\/blood.2021014708.","journal-title":"Blood"},{"issue":"1","key":"4200_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12959-022-00388-w","volume":"20","author":"T Tsuchida","year":"2022","unstructured":"Tsuchida T, Hayakawa M, Kawahara S, et al. Thrombin generation capacity is enhanced by low antithrombin activity and depends on the activity of the related coagulation factors. Thromb J. 2022;20(1):29. https:\/\/doi.org\/10.1186\/s12959-022-00388-w.","journal-title":"Thromb J"},{"issue":"9","key":"4200_CR13","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1055\/s-0043-1768712","volume":"123","author":"J Natorska","year":"2023","unstructured":"Natorska J, Corral J, de la Morena-Barrio, et al. Antithrombin deficiency is associated with prothrombotic plasma fibrin clot phenotype. Thromb Haemost. 2023;123(9):880\u201391. https:\/\/doi.org\/10.1055\/s-0043-1768712.","journal-title":"Thromb Haemost"},{"issue":"1","key":"4200_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12959-022-00443-6","volume":"21","author":"HL Wang","year":"2023","unstructured":"Wang HL, Ruan DD, Wu M, Ji, et al. Identification and characterization of two SERPINC1 mutations causing congenital antithrombin deficiency. Thromb J. 2023;21(1):3. https:\/\/doi.org\/10.1186\/s12959-022-00443-6.","journal-title":"Thromb J"},{"issue":"5","key":"4200_CR15","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jmoldx.2022.01.009","volume":"24","author":"B de la Morena-Barrio","year":"2022","unstructured":"de la Morena-Barrio B, Orlando C, Sanchis-Juan A, et al. Molecular dissection of structural variations involved in antithrombin deficiency. J Mol Diagnostics: JMD. 2022;24(5):462\u201375. https:\/\/doi.org\/10.1016\/j.jmoldx.2022.01.009.","journal-title":"J Mol Diagnostics: JMD"},{"issue":"8","key":"4200_CR16","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1055\/s-0042-1749345","volume":"122","author":"B de la Morena-Barrio","year":"2022","unstructured":"de la Morena-Barrio B, Stephens J, de la Morena-Barrio, et al. Long-Read sequencing identifies the first retrotransposon insertion and resolves structural variants causing antithrombin deficiency. Thromb Haemost. 2022;122(8):1369\u201378. https:\/\/doi.org\/10.1055\/s-0042-1749345.","journal-title":"Thromb Haemost"},{"key":"4200_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2147\/JBM.S416355","volume":"14","author":"A Marco-Rico","year":"2023","unstructured":"Marco-Rico A, Marco-Vera P. Antithrombin deficiency and thrombosis: A wide clinical scenario reported in a single institution. J Blood Med. 2023;14:499\u2013506. https:\/\/doi.org\/10.2147\/JBM.S416355.","journal-title":"J Blood Med"},{"issue":"1","key":"4200_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12959-024-00677-6","volume":"22","author":"SW Lai","year":"2024","unstructured":"Lai SW, Chang CY, Lee HJ, et al. Identification of two point mutations associated with inherited antithrombin deficiency. Thromb J. 2024;22(1):107. https:\/\/doi.org\/10.1186\/s12959-024-00677-6.","journal-title":"Thromb J"},{"issue":"6","key":"4200_CR19","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1111\/j.1365-2516.2008.01830.x","volume":"14","author":"MM Patnaik","year":"2008","unstructured":"Patnaik MM, Moll S. Inherited antithrombin deficiency: a review. Haemophilia: Official J World Federation Hemophilia. 2008;14(6):1229\u201339. https:\/\/doi.org\/10.1111\/j.1365-2516.2008.01830.x.","journal-title":"Haemophilia: Official J World Federation Hemophilia"},{"issue":"11","key":"4200_CR20","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1161\/01.RES.0000103634.69868.4F","volume":"93","author":"M Dewerchin","year":"2003","unstructured":"Dewerchin M, H\u00e9rault JP, Wallays G, et al. Life-threatening thrombosis in mice with targeted Arg48-to-Cys mutation of the heparin-binding domain of antithrombin. Circul Res. 2003;93(11):1120\u20136. https:\/\/doi.org\/10.1161\/01.RES.0000103634.69868.4F.","journal-title":"Circul Res"},{"key":"4200_CR21","doi-asserted-by":"publisher","first-page":"617711","DOI":"10.3389\/fcvm.2020.617711","volume":"7","author":"Z Bereczky","year":"2021","unstructured":"Bereczky Z, Gindele R, Fiatal S, et al. Age and origin of the founder antithrombin Budapest 3 (p.Leu131Phe) Mutation; its high prevalence in the Roma population and its association with cardiovascular diseases. Front Cardiovasc Med. 2021;7:617711. https:\/\/doi.org\/10.3389\/fcvm.2020.617711.","journal-title":"Front Cardiovasc Med"},{"issue":"8","key":"4200_CR22","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1177\/1076029614556744","volume":"21","author":"J Wang","year":"2015","unstructured":"Wang J, Ma HP, Ti AL, H, et al. Prothrombotic SERPINC1 gene polymorphism May affect heparin sensitivity among different ethnicities of Chinese patients receiving heart surgery. Clin Appl thrombosis\/hemostasis: Official J Int Acad Clin Appl Thrombosis\/Hemostasis. 2015;21(8):760\u20137. https:\/\/doi.org\/10.1177\/1076029614556744.","journal-title":"Clin Appl thrombosis\/hemostasis: Official J Int Acad Clin Appl Thrombosis\/Hemostasis"},{"issue":"4","key":"4200_CR23","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/j.1365-2141.1993.tb03142.x","volume":"84","author":"V Chowdhury","year":"1993","unstructured":"Chowdhury V, Olds RJ, Lane DA, et al. Identification of nine novel mutations in type I antithrombin deficiency by heteroduplex screening. Br J Haematol. 1993;84(4):656\u201361. https:\/\/doi.org\/10.1111\/j.1365-2141.1993.tb03142.x.","journal-title":"Br J Haematol"},{"key":"4200_CR24","doi-asserted-by":"publisher","unstructured":"Kimchi-Sarfaty C, Oh JM, Kim IW, et al. A silent polymorphism in the MDR1 gene changes substrate specificity. Volume 315. Science (New York; 2007. pp. 525\u20138. 5811https:\/\/doi.org\/10.1126\/science.1135308.","DOI":"10.1126\/science.1135308"},{"issue":"10","key":"4200_CR25","doi-asserted-by":"publisher","first-page":"868","DOI":"10.20452\/pamw.15371","volume":"130","author":"C Bravo-P\u00e9rez","year":"2020","unstructured":"Bravo-P\u00e9rez C, de la Morena-Barrio ME, Vicente, et al. Antithrombin deficiency as a still underdiagnosed thrombophilia: a primer for internists. Pol Archives Intern Med. 2020;130(10):868\u201377. https:\/\/doi.org\/10.20452\/pamw.15371.","journal-title":"Pol Archives Intern Med"},{"key":"4200_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.thromres.2017.08.023","volume":"158","author":"V Swoboda","year":"2017","unstructured":"Swoboda V, Zervan K, Thom K, et al. Homozygous antithrombin deficiency type II causing neonatal thrombosis. Thromb Res. 2017;158:134\u20137. https:\/\/doi.org\/10.1016\/j.thromres.2017.08.023.","journal-title":"Thromb Res"},{"key":"4200_CR27","doi-asserted-by":"publisher","first-page":"107602962311971","DOI":"10.1177\/10760296231197174","volume":"29","author":"I Malikova","year":"2023","unstructured":"Malikova I, Husakova M, Bilkova, et al. Thrombin generation decrease after LMWH administration in an Antithrombin-Deficient pregnant woman with a homozygous HBS II Mutation. Clinical and applied thrombosis\/hemostasis: official. J Int Acad Clin Appl Thrombosis\/Hemostasis. 2023;29:10760296231197174. https:\/\/doi.org\/10.1177\/10760296231197174.","journal-title":"J Int Acad Clin Appl Thrombosis\/Hemostasis"},{"issue":"6","key":"4200_CR28","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00277-017-2965-2","volume":"96","author":"J Kraft","year":"2017","unstructured":"Kraft J, Sunder-Plassmann R, Mannhalter C, et al. Women with homozygous AT deficiency type II heparin-binding site (HBS) are at high risk of pregnancy loss and pregnancy complications. Ann Hematol. 2017;96(6):1023\u201331. https:\/\/doi.org\/10.1007\/s00277-017-2965-2.","journal-title":"Ann Hematol"},{"issue":"7","key":"4200_CR29","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1172\/JCI10489","volume":"106","author":"K Ishiguro","year":"2000","unstructured":"Ishiguro K, Kojima T, Kadomatsu K, et al. Complete antithrombin deficiency in mice results in embryonic lethality. J Clin Investig. 2000;106(7):873\u20138. https:\/\/doi.org\/10.1172\/JCI10489.","journal-title":"J Clin Investig"},{"issue":"1","key":"4200_CR30","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1111\/bjh.16963","volume":"191","author":"C Bravo-P\u00e9rez","year":"2020","unstructured":"Bravo-P\u00e9rez C, de la Morena-Barrio ME, Palomo, et al. Genotype-phenotype gradient of SERPINC1 variants in a single family reveals a severe compound antithrombin deficiency in a dead embryo. Br J Haematol. 2020;191(1):e32\u20135. https:\/\/doi.org\/10.1111\/bjh.16963.","journal-title":"Br J Haematol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04200-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04200-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04200-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:55:33Z","timestamp":1781643333000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04200-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4200"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04200-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the First Affiliated Hospital of Wenzhou Medical University (KY2022-R193). Written informed consent was obtained from all participants prior to their involvement in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}